Cargando…
Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries
BACKGROUND: Antimicrobial resistance (AMR) poses an increasing public health threat to low- and lower-middle income countries. Recent studies found that in fact poor governance and transparency correlate more strongly with AMR than factors such as antibiotic use. While many African countries now hav...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785006/ https://www.ncbi.nlm.nih.gov/pubmed/35073967 http://dx.doi.org/10.1186/s13756-021-01040-4 |
_version_ | 1784638866966183936 |
---|---|
author | Harant, Anne |
author_facet | Harant, Anne |
author_sort | Harant, Anne |
collection | PubMed |
description | BACKGROUND: Antimicrobial resistance (AMR) poses an increasing public health threat to low- and lower-middle income countries. Recent studies found that in fact poor governance and transparency correlate more strongly with AMR than factors such as antibiotic use. While many African countries now have national action plans (NAPs) on AMR, it is unclear whether information is publicly available on their implementation, surveillance and financing. METHODS: Here, the transparency of information related to AMR national action plans in 15 African countries is assessed, based on a governance framework for AMR action plans. Public availability is assessed for AMR documents, progress reports, AMR surveillance data, budget allocations, as well as bodies and persons responsible for implementation of NAPs. Government websites and search engines were perused using search terms related to the studied criteria and countries. RESULTS: Results show that most countries have a national action plan publicly available. AMR surveillance data was available for a few countries, but systematic progress reports and funding allocations were absent in all but one country. Information on a body mandated to coordinate NAP implementation was available for most countries, but their functionality remain unclear. Most countries have nominated at least one person responsible for AMR nationally. In general, information was often fragmented and frequently available on external, non-government websites. It appears that commitments on AMR made in the often comprehensive NAPs are rarely met in a timely manner, exhibiting rather weak accountability for AMR results. The article provides concrete policy recommendations on how transparency and accountability may be improved with little effort. CONCLUSIONS: Making information available can enable stakeholders such as civil society to demand accountability for results and lead to much needed specific actions on curbing AMR in countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-01040-4. |
format | Online Article Text |
id | pubmed-8785006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87850062022-01-24 Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries Harant, Anne Antimicrob Resist Infect Control Research BACKGROUND: Antimicrobial resistance (AMR) poses an increasing public health threat to low- and lower-middle income countries. Recent studies found that in fact poor governance and transparency correlate more strongly with AMR than factors such as antibiotic use. While many African countries now have national action plans (NAPs) on AMR, it is unclear whether information is publicly available on their implementation, surveillance and financing. METHODS: Here, the transparency of information related to AMR national action plans in 15 African countries is assessed, based on a governance framework for AMR action plans. Public availability is assessed for AMR documents, progress reports, AMR surveillance data, budget allocations, as well as bodies and persons responsible for implementation of NAPs. Government websites and search engines were perused using search terms related to the studied criteria and countries. RESULTS: Results show that most countries have a national action plan publicly available. AMR surveillance data was available for a few countries, but systematic progress reports and funding allocations were absent in all but one country. Information on a body mandated to coordinate NAP implementation was available for most countries, but their functionality remain unclear. Most countries have nominated at least one person responsible for AMR nationally. In general, information was often fragmented and frequently available on external, non-government websites. It appears that commitments on AMR made in the often comprehensive NAPs are rarely met in a timely manner, exhibiting rather weak accountability for AMR results. The article provides concrete policy recommendations on how transparency and accountability may be improved with little effort. CONCLUSIONS: Making information available can enable stakeholders such as civil society to demand accountability for results and lead to much needed specific actions on curbing AMR in countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-01040-4. BioMed Central 2022-01-24 /pmc/articles/PMC8785006/ /pubmed/35073967 http://dx.doi.org/10.1186/s13756-021-01040-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Harant, Anne Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title | Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title_full | Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title_fullStr | Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title_full_unstemmed | Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title_short | Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries |
title_sort | assessing transparency and accountability of national action plans on antimicrobial resistance in 15 african countries |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785006/ https://www.ncbi.nlm.nih.gov/pubmed/35073967 http://dx.doi.org/10.1186/s13756-021-01040-4 |
work_keys_str_mv | AT harantanne assessingtransparencyandaccountabilityofnationalactionplansonantimicrobialresistancein15africancountries |